CDK4 and infection: We then addressed the question of whether the time point of pretreatment with CDK4/6i had an impact on the enhanced oncolytic activity and did not observe any obvious differences between 24 h pretreatment with CDK4/6i before infection or parallel treatment (Supplementary Fig. 1f).